ArticleEuropean journal of epidemiology2026
Projections of the global, regional and national stroke burden by 2050: a systematic analysis for the Global Burden of Disease Study 2021.
Article in European journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between acute infarct topography and cerebral microbleed location in acute ischemic stroke: a retrospective cross-sectional magnetic resonance imaging study.Quantitative imaging in medicine and surgery · 2026Article
- Association of Clinical, Radiological, and Procedural Characteristics with NIHSS at Discharge and 90-Day Modified Rankin Scale Outcomes in Individuals with Stroke Treated with Mechanical Thrombectomy.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
This study projected the incidence, prevalence, death and disability-adjusted life-years (DALYs) attributable to total strokes and pathological types in people aged ≥ 15 years for 204 countries and territories to 2050. Age- and sex-specific trends in rates were developed using XGBoost models incorporating national human development index, gross domestic product per capita, and demographic data from the Global Burden of Disease study, the World Bank, and the United Nations. Uncertainty intervals were calculated as the 2.5th and 97.5th percentiles of the distribution using a bootstrap-like method. From 2021 to 2050, the global absolute number of incident strokes is anticipated to increase by 31.64% (27.78–35.61), prevalent strokes by 58.00% (54.68–60.62), deaths from stroke by 11.88% (5.83–19.28), and DALYs due to stroke by 17.86% (10.63–25.18). Meanwhile, the age-standardised rate of stroke prevalence will increase by 2.67% (1.47–4.23). However, the age-standardised rates of stroke incidence, death and DALYs are projected to decrease by 8.54% (6.87–10.07), 21.51% (19.18–23.92) and 18.44% (15.83–20.95), respectively. In 2050, males are projected to exceed females across all age-standardised metrics. Ischaemic stroke will account for the largest proportion of the total-stroke burden, the burden of stroke in low to middle SDI countries will account for more than half of the total global burden of stroke, and Southeast Asia, East Asia, and Oceania are projected to have the highest stroke burden in absolute numbers. Our projections suggested the global burden of stroke will increase substantially from 2021 to 2050, despite reductions in age-standardised rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.